Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N. Mkhize, Lynn Morris, Talita York et al.|PLoS Pathogens|2023Cited by 57
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, James I. Mullins, Hongjun Bai et al.|Proceedings of the National Academy of Sciences|2024Cited by 22
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, James I. Mullins, Chivonne Moodley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNyaradzo Mgodi, Allan C. deCamp, John Hural et al.|UNC Libraries|2023Cited by 0
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresLawrence Corey, Carolyn Williamson, Hong Zhao et al.|Carolina Digital Repository (University of North Carolina at Chapel Hill)|2025Cited by 0